Cargando…
Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment
Prednisone is often used for the treatment of autoimmune and inflammatory diseases but they suffer from variable therapeutic responses and significant adverse effects. Serum biological markers that are modulated by chronic corticosteroid use have not been identified. Myasthenia gravis is an autoimmu...
Autores principales: | Sengupta, Manjistha, Cheema, Amrita, Kaminski, Henry J., Kusner, Linda L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102553/ https://www.ncbi.nlm.nih.gov/pubmed/25032816 http://dx.doi.org/10.1371/journal.pone.0102635 |
Ejemplares similares
-
Serum metabolomics of treatment response in myasthenia gravis
por: Sikorski, Patricia, et al.
Publicado: (2023) -
MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis
por: Sengupta, Manjistha, et al.
Publicado: (2018) -
Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis
por: Kusner, Linda L., et al.
Publicado: (2019) -
The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis
por: Xie, Yanchen, et al.
Publicado: (2017) -
Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)